512101 — Triochem Products Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for Triochem Products, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 139 | 88.2 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 13.3 | 25.2 | 0 | -0.001 | -0.529 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 145 | 76 | 14.5 | 23 | 13 |
| Operating Profit | -6.06 | 12.2 | -14.5 | -23 | -13 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.81 | 17.6 | -11.7 | -13.3 | -2.46 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.47 | 13.2 | -8.85 | -10.1 | -4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.47 | 13.2 | -8.85 | -10.1 | -4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.47 | 13.2 | -8.85 | -10.1 | -4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -18.2 | 54.2 | -36.1 | -10.7 | -16.3 |